{"count": 8, "results": [{"_id": "34917782", "pmid": 34917782, "pmcid": "PMC8645906", "title": "Focal brain lactate accumulation in metformin-induced encephalopathy without systemic lactic acidosis: A case report suggesting mitochondrial vulnerability in lentiform fork sign", "journal": "eNeurologicalSci", "authors": ["Hanazono A", "Takahashi Y", "Sanpei Y", "Kamada S", "Sugawara M"], "date": "2021-11-29T00:00:00Z", "doi": "10.1016/j.ensci.2021.100383", "meta_date_publication": "2021 Dec", "meta_volume": "25", "meta_issue": "", "meta_pages": "100383", "score": 50278.742, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ causes @DISEASE_Brain_Diseases_Metabolic @DISEASE_MESH:D001928 @@@metabolic encephalopathy@@@ in some @SPECIES_9606 @@@patients@@@ with @DISEASE_Kidney_Failure_Chronic @DISEASE_MESH:D007676 @@@end-stage chronic kidney disease@@@, resulting in @DISEASE_Consciousness_Disorders @DISEASE_MESH:D003244 @@@impaired consciousness@@@ and @<m>DISEASE_Parkinson_Disease_Secondary</m> @DISEASE_MESH:D010302 @@@parkinsonism@@@. ", "citations": {"NLM": "Hanazono A, Takahashi Y, Sanpei Y, Kamada S, Sugawara M. Focal brain lactate accumulation in metformin-induced encephalopathy without systemic lactic acidosis: A case report suggesting mitochondrial vulnerability in lentiform fork sign eNeurologicalSci. 2021 Dec;25():100383. PMID: 34917782", "BibTeX": "@article{34917782, title={Focal brain lactate accumulation in metformin-induced encephalopathy without systemic lactic acidosis: A case report suggesting mitochondrial vulnerability in lentiform fork sign}, author={Hanazono A and Takahashi Y and Sanpei Y and Kamada S and Sugawara M}, journal={eNeurologicalSci}, volume={25}, pages={100383}}"}}, {"_id": "32189544", "pmid": 32189544, "title": "Protective effect of metformin against rotenone-induced parkinsonism in mice.", "journal": "Toxicol Mech Methods", "authors": ["Wang DX", "Chen AD", "Wang QJ", "Xin YY", "Yin J", "Jing YH"], "date": "2020-06-01T00:00:00Z", "doi": "10.1080/15376516.2020.1741053", "meta_date_publication": "2020 Jun", "meta_volume": "30", "meta_issue": "5", "meta_pages": "350-357", "score": 50269.86, "text_hl": "Protective effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ against @CHEMICAL_Rotenone @CHEMICAL_MESH:D012402 @@@rotenone@@@-induced @<m>DISEASE_Parkinson_Disease_Secondary</m> @DISEASE_MESH:D010302 @@@parkinsonism@@@ in @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Wang DX, Chen AD, Wang QJ, Xin YY, Yin J, Jing YH. Protective effect of metformin against rotenone-induced parkinsonism in mice. Toxicol Mech Methods. 2020 Jun;30(5):350-357. PMID: 32189544", "BibTeX": "@article{32189544, title={Protective effect of metformin against rotenone-induced parkinsonism in mice.}, author={Wang DX and Chen AD and Wang QJ and Xin YY and Yin J and Jing YH}, journal={Toxicol Mech Methods}, volume={30}, number={5}, pages={350-357}}"}}, {"_id": "36923829", "pmid": 36923829, "pmcid": "PMC10009720", "title": "Extrapyramidal syndromes of chronic kidney disease and dialysis (diabetic uremic syndrome) with reversible parkinsonism and lentiform fork sign: A case report and literature review including metformin-induced encephalopathy", "journal": "Heliyon", "authors": ["Sakurai T", "Nishida H"], "date": "2023-03-03T00:00:00Z", "doi": "10.1016/j.heliyon.2023.e14255", "meta_date_publication": "2023 Mar", "meta_volume": "9", "meta_issue": "3", "meta_pages": "e14255", "score": 50261.71, "text_hl": "We report a case of a @SPECIES_9606 @@@patient@@@ on maintenance hemodialysis for @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@ who was taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and developed subacute @<m>DISEASE_Parkinson_Disease_Secondary</m> @DISEASE_MESH:D010302 @@@parkinsonism@@@ and bilateral @DISEASE_Basal_Ganglia_Diseases @DISEASE_MESH:D001480 @@@basal ganglia lesions@@@ that rapidly improved after discontinuation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with continued maintenance hemodialysis. ", "citations": {"NLM": "Sakurai T, Nishida H. Extrapyramidal syndromes of chronic kidney disease and dialysis (diabetic uremic syndrome) with reversible parkinsonism and lentiform fork sign: A case report and literature review including metformin-induced encephalopathy Heliyon. 2023 Mar;9(3):e14255. PMID: 36923829", "BibTeX": "@article{36923829, title={Extrapyramidal syndromes of chronic kidney disease and dialysis (diabetic uremic syndrome) with reversible parkinsonism and lentiform fork sign: A case report and literature review including metformin-induced encephalopathy}, author={Sakurai T and Nishida H}, journal={Heliyon}, volume={9}, number={3}, pages={e14255}}"}}, {"_id": "39181309", "pmid": 39181309, "title": "Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry", "authors": ["Zhao Y", "Fei L", "Duan Y"], "date": "2024-08-22T00:00:00Z", "doi": "10.1016/j.pnpbp.2024.111128", "meta_date_publication": "2024 Aug 22", "meta_volume": "135", "meta_issue": "", "meta_pages": "111128", "score": 50238.504, "text_hl": "The combined therapeutic effects of multiple genetic variants of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, especially @GENE_PRKAB1 @GENE_5564 @@@AMP-activated protein kinase@@@ (@GENE_PRKAB1 @GENE_5564 @@@AMPK@@@) were markedly linked to a greater likelihood of developing secondary @<m>DISEASE_Parkinson_Disease_Secondary</m> @DISEASE_MESH:D010302 @@@parkinsonism@@@ (OR:10.816, p = 0.049) according to MR analyses. ", "citations": {"NLM": "Zhao Y, Fei L, Duan Y. Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 22;135():111128. PMID: 39181309", "BibTeX": "@article{39181309, title={Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.}, author={Zhao Y and Fei L and Duan Y}, journal={Prog Neuropsychopharmacol Biol Psychiatry}, volume={135}, pages={111128}}"}}, {"_id": "38040547", "pmid": 38040547, "title": "Importance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting alpha-synuclein and neuroprotection in the treatment of Parkinson's disease.", "journal": "Rev Neurol (Paris)", "authors": ["Siddique AHH", "Kale PP"], "date": "2023-11-30T00:00:00Z", "doi": "10.1016/j.neurol.2023.08.011", "meta_date_publication": "2023 Nov 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50234.66, "text_hl": "The current study focuses on treatment options for disorders associated with the @GENE_PGK1 @GENE_5230 @@@pgk-1@@@ enzyme, @GENE_GLP1R @GENE_2740 @@@GLP-1@@@, and @VARIANT_c.2A>A_GLP1R_human @VARIANT_tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;CorrespondingGene:2740;CorrespondingSpecies:9606 @@@A2A@@@ receptor which can be utilized to treat @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@PD@@@. A combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Terazosin @CHEMICAL_MESH:C041226 @@@terazosin@@@, @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@exenatide@@@ and @CHEMICAL_Meclizine @CHEMICAL_MESH:D008468 @@@meclizine@@@, @CHEMICAL_istradefylline @CHEMICAL_MESH:C111599 @@@istradefylline@@@ and @CHEMICAL_Albuterol @CHEMICAL_MESH:D000420 @@@salbutamol@@@ treatments may benefit @<m>DISEASE_Parkinson_Disease_Secondary</m> @DISEASE_MESH:D010302 @@@parkinsonism@@@. ", "citations": {"NLM": "Siddique AHH, Kale PP. Importance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting alpha-synuclein and neuroprotection in the treatment of Parkinson's disease. Rev Neurol (Paris). 2023 Nov 30;():. PMID: 38040547", "BibTeX": "@article{38040547, title={Importance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting alpha-synuclein and neuroprotection in the treatment of Parkinson's disease.}, author={Siddique AHH and Kale PP}, journal={Rev Neurol (Paris)}}"}}, {"_id": "29415360", "pmid": 29415360, "title": "Metformin-induced encephalopathy: the role of thiamine.", "journal": "Intern Med J", "authors": ["McGarvey C", "Franconi C", "Prentice D", "Bynevelt M"], "date": "2018-02-01T00:00:00Z", "doi": "10.1111/imj.13693", "meta_date_publication": "2018 Feb", "meta_volume": "48", "meta_issue": "2", "meta_pages": "194-197", "score": 50058.703, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-induced @DISEASE_Brain_Diseases @DISEASE_MESH:D001927 @@@encephalopathy@@@: the role of @CHEMICAL_Thiamine @CHEMICAL_MESH:D013831 @@@thiamine@@@.", "citations": {"NLM": "McGarvey C, Franconi C, Prentice D, Bynevelt M. Metformin-induced encephalopathy: the role of thiamine. Intern Med J. 2018 Feb;48(2):194-197. PMID: 29415360", "BibTeX": "@article{29415360, title={Metformin-induced encephalopathy: the role of thiamine.}, author={McGarvey C and Franconi C and Prentice D and Bynevelt M}, journal={Intern Med J}, volume={48}, number={2}, pages={194-197}}"}}, {"_id": "31645842", "pmid": 31645842, "pmcid": "PMC6806136", "title": "Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5Y cells", "journal": "EXCLI J", "authors": ["Chanthammachat P", "Dharmasaroja P"], "date": "2019-09-10T00:00:00Z", "doi": "10.17179/excli2019-1703", "meta_date_publication": "2019", "meta_volume": "18", "meta_issue": "", "meta_pages": "812-823", "score": 50046.406, "text_hl": "These results suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ pretreatment protects against MPP+-induced @DISEASE_Neurotoxicity_Syndromes @DISEASE_MESH:D020258 @@@neurotoxicity@@@, and offer insights into the potential role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in protecting against toxin-induced @<m>DISEASE_Parkinson_Disease_Secondary</m> @DISEASE_MESH:D010302 @@@parkinsonism@@@.", "citations": {"NLM": "Chanthammachat P, Dharmasaroja P. Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5Y cells EXCLI J. 2019;18():812-823. PMID: 31645842", "BibTeX": "@article{31645842, title={Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5Y cells}, author={Chanthammachat P and Dharmasaroja P}, journal={EXCLI J}, volume={18}, pages={812-823}}"}}, {"_id": "26997732", "pmid": 26997732, "pmcid": "PMC4778217", "title": "Linezolid and Rasagiline - A culprit for serotonin syndrome", "journal": "Indian J Pharmacol", "authors": ["Hisham M", "Sivakumar MN", "Nandakumar V", "Lakshmikanthcharan S"], "date": "2016-01-01T00:00:00Z", "doi": "10.4103/0253-7613.174573", "meta_date_publication": "2016 Jan-Feb", "meta_volume": "48", "meta_issue": "1", "meta_pages": "91-2", "score": 50044.69, "text_hl": "She had a history of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ and @<m>DISEASE_Parkinson_Disease_Secondary</m> @DISEASE_MESH:D010302 @@@parkinsonism@@@ on @CHEMICAL_carbidopa_levodopa_drug_combination @CHEMICAL_MESH:C009265 @@@levodopa/carbidopa@@@, @CHEMICAL_rasagiline @CHEMICAL_MESH:C031967 @@@rasagiline@@@, @CHEMICAL_ropinirole @CHEMICAL_MESH:C046649 @@@ropinirole@@@, @CHEMICAL_Trihexyphenidyl @CHEMICAL_MESH:D014282 @@@trihexyphenidyl@@@, @CHEMICAL_Amantadine @CHEMICAL_MESH:D000547 @@@amantadine@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Glipizide @CHEMICAL_MESH:D005913 @@@glipizide@@@. ", "citations": {"NLM": "Hisham M, Sivakumar MN, Nandakumar V, Lakshmikanthcharan S. Linezolid and Rasagiline - A culprit for serotonin syndrome Indian J Pharmacol. 2016 Jan-Feb;48(1):91-2. PMID: 26997732", "BibTeX": "@article{26997732, title={Linezolid and Rasagiline - A culprit for serotonin syndrome}, author={Hisham M and Sivakumar MN and Nandakumar V and Lakshmikanthcharan S}, journal={Indian J Pharmacol}, volume={48}, number={1}, pages={91-2}}"}}]}